PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
03 2020
Historique:
received: 11 02 2019
accepted: 09 08 2019
pubmed: 16 8 2019
medline: 28 4 2021
entrez: 16 8 2019
Statut: ppublish

Résumé

Hereditary xerocytosis is a dominantly inherited red cell membrane disorder caused in most cases by gain-of-function mutations in PIEZO1, encoding a mechanosensitive ion channel that translates a mechanic stimulus into calcium influx. We found that PIEZO1 was expressed early in erythroid progenitor cells, and investigated whether it could be involved in erythropoiesis, besides having a role in the homeostasis of mature red cell hydration. In UT7 cells, chemical PIEZO1 activation using YODA1 repressed glycophorin A expression by 75%. This effect was PIEZO1-dependent since it was reverted using specific short hairpin-RNA knockdown. The effect of PIEZO1 activation was confirmed in human primary progenitor cells, maintaining cells at an immature stage for longer and modifying the transcriptional balance in favor of genes associated with early erythropoiesis, as shown by a high

Identifiants

pubmed: 31413092
pii: haematol.2019.218503
doi: 10.3324/haematol.2019.218503
pmc: PMC7049340
doi:

Substances chimiques

Ion Channels 0
PIEZO1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

610-622

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

PLoS One. 2016 Jan 05;11(1):e0146201
pubmed: 26731108
Cell Rep. 2017 Nov 28;21(9):2357-2366
pubmed: 29186675
Blood. 2015 Mar 12;125(11):1841
pubmed: 25927085
Blood. 2003 Dec 1;102(12):3938-46
pubmed: 12907435
Blood. 2013 Apr 18;121(16):3216-27
pubmed: 23327923
Science. 2010 Oct 1;330(6000):55-60
pubmed: 20813920
Blood. 2012 Aug 30;120(9):1908-15
pubmed: 22529292
Genes Dev. 2003 Sep 15;17(18):2205-32
pubmed: 12975316
Blood. 2014 Dec 4;124(24):3636-45
pubmed: 25339359
Oncotarget. 2017 Dec 28;9(11):9632-9644
pubmed: 29515759
Nature. 2018 Feb 22;554(7693):481-486
pubmed: 29261642
Int J Hematol. 2014 Nov;100(5):417-24
pubmed: 24638828
Haematologica. 2019 Aug;104(8):1554-1564
pubmed: 30655378
Nature. 2017 Mar 2;543(7643):118-121
pubmed: 28199303
Nature. 2014 Nov 13;515(7526):279-282
pubmed: 25119035
Elife. 2015 May 22;4:
pubmed: 26001275
Cell Rep. 2016 Aug 2;16(5):1470-1484
pubmed: 27452463
Haematologica. 2019 May;104(5):e179-e183
pubmed: 30237269
Blood. 2011 Dec 8;118(24):6258-68
pubmed: 21998215
Blood. 2014 May 29;123(22):3466-77
pubmed: 24637361
Blood. 2013 May 9;121(19):3925-35, S1-12
pubmed: 23479567
J Biol Chem. 2014 Jun 6;289(23):16565-75
pubmed: 24759099
Nat Commun. 2013;4:1884
pubmed: 23695678
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11783-8
pubmed: 26351678
Cell. 1995 Jan 27;80(2):179-85
pubmed: 7834738
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1162-8
pubmed: 23487776
Blood. 1998 Aug 15;92(4):1142-9
pubmed: 9694701
Blood. 2017 Dec 21;130(25):2699-2708
pubmed: 29051181
Blood. 2005 Jan 15;105(2):600-8
pubmed: 15358619
Br J Haematol. 2005 Jul;130(1):121-9
pubmed: 15982354
Haematologica. 2019 Mar;104(3):e91-e93
pubmed: 30237267
PLoS One. 2015 May 08;10(5):e0125503
pubmed: 25955826
Nature. 2018 Feb 22;554(7693):487-492
pubmed: 29469092
Blood. 2013 Apr 18;121(16):3246-53
pubmed: 23422750
Pediatr Blood Cancer. 2018 Jul;65(7):e27053
pubmed: 29603612
Blood. 2017 Oct 19;130(16):1845-1856
pubmed: 28716860
Haematologica. 2017 Oct;102(10):e415-e418
pubmed: 28619848
Cell. 2018 Apr 5;173(2):443-455.e12
pubmed: 29576450
Blood. 1997 Jan 1;89(1):92-100
pubmed: 8978281
Elife. 2018 Aug 22;7:
pubmed: 30132757
Int J Lab Hematol. 2018 May;40 Suppl 1:68-73
pubmed: 29741259
Elife. 2015 May 22;4:
pubmed: 26001274
Blood. 2004 Sep 15;104(6):1679-87
pubmed: 15166036
Blood. 2005 Feb 15;105(4):1448-55
pubmed: 15507521
Biochem Biophys Res Commun. 2018 Feb 26;497(1):220-225
pubmed: 29428723
J Biol Chem. 2002 Sep 13;277(37):34375-82
pubmed: 12167663

Auteurs

Alexis Caulier (A)

EA4666 HEMATIM, Université Picardie Jules Verne, Amiens.
Service des Maladies du Sang, CHU Amiens, Amiens.

Nicolas Jankovsky (N)

EA4666 HEMATIM, Université Picardie Jules Verne, Amiens.

Yohann Demont (Y)

Unité de Thérapie Cellulaire, CHU Amiens, Amiens.

Hakim Ouled-Haddou (H)

EA4666 HEMATIM, Université Picardie Jules Verne, Amiens.

Julien Demagny (J)

Service d'Hématologie Biologique, CHU Amiens.

Corinne Guitton (C)

Service de Pédiatrie Générale, CHU Bicêtre, AP-HP, Le Kremlin-Bicêtre.

Lavinia Merlusca (L)

Service des Maladies du Sang, CHU Amiens, Amiens.

Delphine Lebon (D)

EA4666 HEMATIM, Université Picardie Jules Verne, Amiens.
Service des Maladies du Sang, CHU Amiens, Amiens.

Pascal Vong (P)

EA4666 HEMATIM, Université Picardie Jules Verne, Amiens.

Aurélien Aubry (A)

EA4666 HEMATIM, Université Picardie Jules Verne, Amiens.

Agnès Lahary (A)

Laboratoire d'Hématologie, CHU Rouen, Rouen.

Christian Rose (C)

Service d'Oncologie et d'Hématologie, Hôpital Saint Vincent de Paul, Lille.

Sandrine Gréaume (S)

Etablissement Français du Sang (EFS) de Normandie, Bois-Guillaume.

Emilie Cardon (E)

EA4666 HEMATIM, Université Picardie Jules Verne, Amiens.

Jessica Platon (J)

EA4666 HEMATIM, Université Picardie Jules Verne, Amiens.

Halima Ouadid-Ahidouch (H)

EA4667 Laboratoire de Physiologie Cellulaire et Moléculaire, Université Picardie Jules Verne, Amiens.

Jacques Rochette (J)

EA4666 HEMATIM, Université Picardie Jules Verne, Amiens.
Laboratoire de Génétique Moléculaire, CHU Amiens, Amiens.

Jean-Pierre Marolleau (JP)

EA4666 HEMATIM, Université Picardie Jules Verne, Amiens.
Service des Maladies du Sang, CHU Amiens, Amiens.

Véronique Picard (V)

Laboratoire d'Hématologie, AP-HP, Le Kremlin-Bicêtre, France.

Loïc Garçon (L)

EA4666 HEMATIM, Université Picardie Jules Verne, Amiens garcon.loic@chu-amiens.fr.
Service d'Hématologie Biologique, CHU Amiens.
Laboratoire de Génétique Moléculaire, CHU Amiens, Amiens.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH